EnteroMedics Inc (NASDAQ:ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced the …
EnteroMedics Inc (NASDAQ:ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced financial …
EnteroMedics Inc (NASDAQ:ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced the publication …
Analysts are weighing in on obesity-device maker EnteroMedics Inc (NASDAQ:ETRM), stem cell company Athersys, Inc. (NASDAQ:ATHX) and cancer vaccine maker Inovio Pharmaceuticals Inc (NASDAQ:INO), with price targets ranging from …
EnteroMedics Inc (NASDAQ:ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that …
Following third quarter earnings, analysts are bullish on immunotherapy company Cytosorbents Corp (NASDAQ:CTSO) and EnteroMedics Inc (NASDAQ:ETRM) thanks to the companies’ cutting edge treatments. …
Canaccord analyst William Plovanic weighed in today with an optimistic view on EnteroMedics Inc (NASDAQ:ETRM), following the company’s recent second-quarter results and a presentation at the …
EnteroMedics Inc (NASDAQ:ETRM) the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced financial …
EnteroMedics Inc (NASDAQ:ETRM), the developer of medical devices using neuroblocking therapy to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that Lori C. …
